Joseph M. Ahearn

Mapping of the Epstein-Barr virus and C3dg binding sites to a common domain on complement receptor type 2

D. Fearon, R. Carter, J. Ahearn, 1989, The Journal of experimental medicine.

Antibody response to a T-dependent antigen requires B cell expression of complement receptors

G. Kelsoe, J. Ahearn, S. Han, 1996, The Journal of experimental medicine.

Structure and function of the complement receptors, CR1 (CD35) and CR2 (CD21).

D. Fearon, J. Ahearn, Joseph M. Ahearn, 1989, Advances in immunology.

Suppression of the immune response by a soluble complement receptor of B lymphocytes.

D. Fearon, J. Ahearn, T. Hebell, 1991, Science.

Determination of the structural basis for selective binding of Epstein- Barr virus to human complement receptor type 2

Don R. Martin, Douglas T Fearon, Joseph M. Ahearn, 1991, The Journal of experimental medicine.

Interrelationships of HLA-DR, MB, and MT phenotypes, autoantibody expression, and clinical features in systemic lupus erythematosus.

F. Arnett, J. Ahearn, W. Bias, 1982, Arthritis and rheumatism.